AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Flo, TH Halaas, O Torp, S Ryan, L Lien, E Dybdahl, B Sundan, A Espevik, T
Citation: Th. Flo et al., Differential expression of Toll-like receptor 2 in human cells, J LEUK BIOL, 69(3), 2001, pp. 474-481

Authors: Medvedev, AE Henneke, P Schromm, A Lien, E Ingalls, R Fenton, MJ Golenbock, DT Vogel, SN
Citation: Ae. Medvedev et al., Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of toll-like receptors 2 or 4, J IMMUNOL, 167(4), 2001, pp. 2257-2267

Authors: Schromm, AB Lien, E Henneke, P Chow, JC Yoshimura, A Heine, H Latz, E Monks, BG Schwartz, DA Miyake, K Golenbock, DT
Citation: Ab. Schromm et al., Molecular genetic analysis of an endotoxin nonresponder mutant cell Line: A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling, J EXP MED, 194(1), 2001, pp. 79-88

Authors: Lien, E Chow, JC Hawkins, LD McGuinness, PD Miyake, K Espevik, T Gusovsky, F Golenbock, DT
Citation: E. Lien et al., A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway, J BIOL CHEM, 276(3), 2001, pp. 1873-1880

Authors: Ingalls, RR Lien, E Golenbock, DT
Citation: Rr. Ingalls et al., Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2, INFEC IMMUN, 69(4), 2001, pp. 2230-2236

Authors: Gullestad, L Aass, H Fjeld, JG Wikeby, L Andreassen, AK Ihlen, H Simonsen, S Kjekshus, J Nitter-Hauge, S Ueland, T Lien, E Froland, SS Aukrust, P
Citation: L. Gullestad et al., Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure, CIRCULATION, 103(2), 2001, pp. 220-225

Authors: Liabakk, NB Waage, A Lien, E Stenvik, J Espevik, T
Citation: Nb. Liabakk et al., Cytokine bioassays, METH MOL M, 67, 2001, pp. 487-497

Authors: Ingalls, RR Lien, E Golenbock, DT
Citation: Rr. Ingalls et al., Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis, J ENDOTOX R, 6(5), 2000, pp. 411-415

Authors: Lien, E Heine, H Golenbock, DT
Citation: E. Lien et al., LPS receptors, UPD INT CAR, 31, 2000, pp. 164-172

Authors: Field, CJ Thomson, CA Van Aerde, JE Parrott, A Euler, A Lien, E Clandinin, MT
Citation: Cj. Field et al., Lower proportion of CD45R0(+) cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids, J PED GASTR, 31(3), 2000, pp. 291-299

Authors: Nordoy, I Muller, F Nordal, KP Rollag, H Lien, E Aukrust, P Froland, SS
Citation: I. Nordoy et al., The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients, J INFEC DIS, 181(1), 2000, pp. 51-57

Authors: Flo, TH Halaas, O Lien, E Ryan, L Teti, G Golenbock, DT Sundan, A Espevik, T
Citation: Th. Flo et al., Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide, J IMMUNOL, 164(4), 2000, pp. 2064-2069

Authors: Lien, E Means, TK Heine, H Yoshimura, A Kusumoto, S Fukase, K Fenton, MJ Oikawa, M Qureshi, N Monks, B Finberg, RW Ingalls, RR Golenbock, DT
Citation: E. Lien et al., Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide, J CLIN INV, 105(4), 2000, pp. 497-504

Authors: Ingalls, RR Heine, H Lien, E Yoshimura, A Golenbock, D
Citation: Rr. Ingalls et al., Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors, INF DIS CL, 13(2), 1999, pp. 341

Authors: Clandinin, MT Van Aerde, JE Parrott, A Field, CJ Euler, AR Lien, E
Citation: Mt. Clandinin et al., Assessment of feeding different amounts of arachidonic and docosahexaenoicacids in preterm infant formulas on the fatty acid content of lipoprotein lipids, ACT PAEDIAT, 88(8), 1999, pp. 890-896

Authors: Nordoy, I Muller, F Nordal, KP Rollag, H Lien, E Aukrust, P Froland, SS
Citation: I. Nordoy et al., Immunologic parameters as predictive factors of cytomegalovirus disease inrenal allograft recipients, J INFEC DIS, 180(1), 1999, pp. 195-198

Authors: Aukrust, P Muller, F Lien, E Nordoy, I Liabakk, NB Kvale, D Espevik, T Froland, SS
Citation: P. Aukrust et al., Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure, J INFEC DIS, 179(1), 1999, pp. 74-82

Authors: Means, TK Wang, SY Lien, E Yoshimura, A Golenbock, DT Fenton, MJ
Citation: Tk. Means et al., Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis, J IMMUNOL, 163(7), 1999, pp. 3920-3927

Authors: Sellati, TJ Bouis, DA Caimano, MJ Feulner, JA Ayers, C Lien, E Radolf, JD
Citation: Tj. Sellati et al., Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins, J IMMUNOL, 163(4), 1999, pp. 2049-2056

Authors: Means, TK Lien, E Yoshimura, A Wang, SY Golenbock, DT Fenton, MJ
Citation: Tk. Means et al., The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for toll-like receptors, J IMMUNOL, 163(12), 1999, pp. 6748-6755

Authors: Yoshimura, A Lien, E Ingalls, RR Tuomanen, E Dziarski, R Golenbock, D
Citation: A. Yoshimura et al., Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2, J IMMUNOL, 163(1), 1999, pp. 1-5

Authors: Heine, H Kirschning, CJ Lien, E Monks, BG Rothe, M Golenbock, DT
Citation: H. Heine et al., Cutting edge: Cells that carry a null allele for toll-like receptor 2 are capable of responding to endotoxin, J IMMUNOL, 162(12), 1999, pp. 6971-6975

Authors: Aukrust, P Haug, CJ Ueland, T Lien, E Muller, F Espevik, T Bollerslev, J Froland, SS
Citation: P. Aukrust et al., Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy, J CLIN END, 84(1), 1999, pp. 145-150

Authors: Lien, E Sellati, TJ Yoshimura, A Flo, TH Rawadi, G Finberg, RW Carroll, JD Espevik, T Ingalls, RR Radolf, JD Golenbock, DT
Citation: E. Lien et al., Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products, J BIOL CHEM, 274(47), 1999, pp. 33419-33425

Authors: Aukrust, P Ueland, T Lien, E Bendtzen, K Muller, F Andreassen, AK Nordoy, I Aass, H Espevik, T Simonsen, S Froland, SS Gullestad, L
Citation: P. Aukrust et al., Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, AM J CARD, 83(3), 1999, pp. 376-382
Risultati: 1-25 |